Firalis S.A. (“Firalis”), a Huningue based developer and provider of biomarker products and bioanalytical... read more
Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that it has signed a commercialization plan with Pfizer Inc. The plan is under an existing... read more
Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced that it has raised $40 million in a Series C financing... read more
... read more
Vaxart Stock is up over 165% after after the biotechnology company announced results from a phase 2 trial that its oral flu vaccine performed better than Sanofi's Fluzone.
"These latest... read more